Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


Articles published in Am J Kidney Dis

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    February 2024
  1. TANG C, Chen P, Si FL, Lv JC, et al
    Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
    PubMed     Abstract available


    January 2024
  2. MIGNANO SE, Pascal V, Odioemene NE, Forehand W, et al
    Monoclonal Immunoglobulin Crystalline Membranous Nephropathy.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(24)00041.
    PubMed     Abstract available


  3. BECK LH JR
    Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
    Am J Kidney Dis. 2024 Jan 22:S0272-6386(23)00995.
    PubMed    


  4. PAUEKSAKON P, Najafian B, Alpers CE, Fogo AB, et al
    AJKD Atlas of Renal Pathology: IgA-Dominant Infection-Related Glomerulonephritis.
    Am J Kidney Dis. 2024;83:e1-e2.
    PubMed    


  5. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    PubMed     Abstract available


    December 2023
  6. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    PubMed     Abstract available


  7. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    PubMed     Abstract available


  8. CANNEY M, Gunning HM, Johnston JC, Induruwage D, et al
    Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Am J Kidney Dis. 2023;82:725-736.
    PubMed     Abstract available


    September 2023
  9. PODESTA MA, Trillini M, Portalupi V, Gennarini A, et al
    Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy.
    Am J Kidney Dis. 2023 Sep 28:S0272-6386(23)00838.
    PubMed     Abstract available


  10. CASTER DJ, Lafayette RA
    The Treatment of Primary IgA Nephropathy: Change, Change, Change.
    Am J Kidney Dis. 2023 Sep 22:S0272-6386(23)00831.
    PubMed     Abstract available


  11. AFOLABI H, Zhang BM, O'Shaughnessy M, Chertow GM, et al
    The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Am J Kidney Dis. 2023 Sep 18:S0272-6386(23)00797.
    PubMed     Abstract available


  12. KEARNEY AO, Lerma E, Lin J
    Building Towards Clinical Translation: New Study Refines Genetic Architecture of IgA Nephropathy.
    Am J Kidney Dis. 2023 Sep 14:S0272-6386(23)00794.
    PubMed    


  13. ELEY S, Morales-Alvarez MC, Vanguri VK, Chopra B, et al
    An Unusual Case of Anti-Glomerular Basement Membrane Disease and PLA2R-Associated Membranous Nephropathy After Exposure to Hydrocarbons.
    Am J Kidney Dis. 2023 Sep 13:S0272-6386(23)00793.
    PubMed     Abstract available


    April 2023
  14. CERVANTES CE, Bloch EM, Sperati CJ
    Therapeutic Plasma Exchange: Core Curriculum 2023.
    Am J Kidney Dis. 2023;81:475-492.
    PubMed     Abstract available


    December 2022
  15. GENEST DS, Patriquin CJ, Licht C, John R, et al
    Renal Thrombotic Microangiopathy: A Review.
    Am J Kidney Dis. 2022 Dec 9:S0272-6386(22)01056.
    PubMed     Abstract available


  16. CANNEY M, Gunning HM, Zheng Y, Rose C, et al
    The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
    Am J Kidney Dis. 2022;80:740-750.
    PubMed     Abstract available


    November 2022
  17. KUANG H, Liu J, Jia XY, Cui Z, et al
    Autoimmunity in Anti-Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy.
    Am J Kidney Dis. 2022 Nov 2. pii: S0272-6386(22)00855.
    PubMed     Abstract available


    October 2022
  18. JAVAUGUE V, Said SM, Bu L, Bridoux F, et al
    Prognostic Value of Diffuse Crescentic Lesions in Fibrillary Glomerulonephritis.
    Am J Kidney Dis. 2022 Oct 10. pii: S0272-6386(22)00927.
    PubMed    


    September 2022
  19. SAHA MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, et al
    Glomerular Hematuria and the Utility of Urine Microscopy: A Review.
    Am J Kidney Dis. 2022;80:383-392.
    PubMed     Abstract available


  20. YU X, Chen N, Xue J, Mok CC, et al
    Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
    Am J Kidney Dis. 2022 Sep 1. pii: S0272-6386(22)00860.
    PubMed     Abstract available


    August 2022
  21. KUDOSE S, Batal I, Lucia J, Patel P, et al
    Proliferative Glomerulonephritis With Hidden Monotypic IgG3kappa Deposits: A Case Report.
    Am J Kidney Dis. 2022 Aug 2. pii: S0272-6386(22)00822.
    PubMed     Abstract available


    July 2022
  22. MARLAIS M, Wlodkowski T, Printza N, Kronsteiner D, et al
    Clinical Factors and Adverse Kidney Outcomes in Children With ANCA-Associated Glomerulonephritis.
    Am J Kidney Dis. 2022 Jul 7. pii: S0272-6386(22)00772.
    PubMed    


    June 2022
  23. LIANG KV, Ellis BK, Stokes MB, Smith RJ, et al
    Hematuria and Proteinuria in a Patient With Recurrent Pulmonary Illnesses: A Quiz.
    Am J Kidney Dis. 2022;79:A13-A15.
    PubMed    


    April 2022
  24. KANT S, Kronbichler A, Sharma P, Geetha D, et al
    Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
    Am J Kidney Dis. 2022;79:582-600.
    PubMed     Abstract available


    March 2022
  25. LUO J, Yuan Y, Tian J, Zhou Z, et al
    Clinicopathological Characteristics and Outcomes of PLA2R-Associated Membranous Nephropathy in Seropositive Patients Without PLA2R Staining on Kidney Biopsy.
    Am J Kidney Dis. 2022 Mar 11. pii: S0272-6386(22)00528.
    PubMed     Abstract available


    February 2022
  26. ROVIN BH
    Kidney Failure in Systemic Lupus Erythematosus: A Fraught Complication in a Fraught Disease.
    Am J Kidney Dis. 2022 Feb 3. pii: S0272-6386(21)01044.
    PubMed    


    December 2021
  27. TANG X, VanBeek C, Haas M, Cook HT, et al
    Cell-Mediated Glomerulonephritis Without Immune Complexes in Native Kidney Biopsies: A Report of 7 Cases.
    Am J Kidney Dis. 2021 Dec 30. pii: S0272-6386(21)01050.
    PubMed     Abstract available


    November 2021
  28. DERNER O, Kramer A, Hruskova Z, Arici M, et al
    Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.
    Am J Kidney Dis. 2021 Nov 6. pii: S0272-6386(21)00954.
    PubMed     Abstract available


  29. FENAROLI P, Rossi GM, Angelotti ML, Antonelli G, et al
    Collapsing Glomerulopathy as a Complication of Type I Interferon-Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutieres Syndrome.
    Am J Kidney Dis. 2021;78:750-754.
    PubMed     Abstract available


    October 2021
  30. SANTORO D, Debiec H, Longhitano E, Torreggiani M, et al
    Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
    Am J Kidney Dis. 2021 Oct 29. pii: S0272-6386(21)00950.
    PubMed     Abstract available


  31. LIM CC, Choo J, Tan CS
    COVID-19 Vaccination in Immunoglobulin A Nephropathy.
    Am J Kidney Dis. 2021;78:617.
    PubMed    


  32. SHAKOOR MT, Birkenbach MP, Lynch M
    ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.
    Am J Kidney Dis. 2021;78:611-613.
    PubMed     Abstract available


    September 2021
  33. NASR SH, Leung N, Said SM, Alkhateeb HB, et al
    Membranous Nephropathy With Extensive Tubular Basement Membrane Deposits Following Allogeneic Hematopoietic Cell Transplant: A Report of 5 Cases.
    Am J Kidney Dis. 2021 Sep 8. pii: S0272-6386(21)00840.
    PubMed     Abstract available


    August 2021
  34. IDREES N, Beck LH Jr
    Multitarget Combination Immunosuppressive Therapy for Primary Membranous Nephropathy.
    Am J Kidney Dis. 2021 Aug 28. pii: S0272-6386(21)00709.
    PubMed    


  35. WASIK H, Chadha V, Galbiati S, Warady B, et al
    Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study.
    Am J Kidney Dis. 2021 Aug 27. pii: S0272-6386(21)00825.
    PubMed     Abstract available


  36. AMIN K, Choksi V, Farouk SS, Sparks MA, et al
    Diarrhea in a Patient With Combined Kidney-Pancreas Transplant.
    Am J Kidney Dis. 2021;78:A13-A16.
    PubMed    


    July 2021
  37. PATTRAPORNPISUT P, Avila-Casado C, Reich HN
    IgA Nephropathy: Core Curriculum 2021.
    Am J Kidney Dis. 2021 Jul 9. pii: S0272-6386(21)00598.
    PubMed     Abstract available


    June 2021
  38. ZONOZI R, Laliberte K, Huizenga NR, Rosenthal JK, et al
    Combination of Rituximab, Low-dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
    Am J Kidney Dis. 2021 Jun 23. pii: S0272-6386(21)00690.
    PubMed     Abstract available


  39. RONSIN C, Georges M, Chapelet-Debout A, Augusto JF, et al
    ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
    Am J Kidney Dis. 2021 Jun 10. pii: S0272-6386(21)00637.
    PubMed     Abstract available


    May 2021
  40. KUKLA A, Ventura-Aguiar P, Cooper M, de Koning EJP, et al
    Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review.
    Am J Kidney Dis. 2021 May 13. pii: S0272-6386(21)00600.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.